BofC
BofC · page 40
- CBD Market
Can Aurora right-size the ship?
Aurora moved from its stock listing from the NYSE to NASDAQ this week as part of its cost-cutting and right-sizing plans, according to a press release.
- Your #1 Podcast on Cannabis News
A look inside a state-of-the-art extraction facility
On May 6, Business of Cannabis hosted a virtual Town Hall with Meni Morim, CEO, Namaste Technologies.
- Uncategorized
Reflections and Trends to Look for Since the Legalization of Recreational Cannabis in Canada
By: Andrew Wilder and Siena Hilley Bland, Cannabis Law Group, Torkin Manes LLP In October 2018, Canada became the second country in the world to legalize the production, use and sale of recreational cannabis.
- Cultivation
Real talk from Tantalus CEO Dan Sutton
Citing high excise taxes as a major pain point, Tantalus CEO Dan Sutton delivered a crushing reality check to those following the industry.
- Adult-Use
Some states are clinging to prohibition
Even though the vast majority of Americans now support cannabis legalization, there are some states where elected representatives are very actively working against it — sometimes using undemocratic methods, reports Forbes.
- Hemp Industry
A company at the intersection of cannabis, technology and international sector expansion
On this episode of BofC Live, we connect with Frank Qin, CEO of Mary Ag.
- Your #1 Podcast on Cannabis News
Understanding lab testing in psychedelics
On this episode of BofC Live, we connect with Ellen Wang from CannDelta.
- Uncategorized
Canadian ETFs are riding high — thanks to the US
In the last year, cannabis ETFs Purpose and Horizons have returned 157.42% and 136.36% respectively, which is significantly higher than big funds like the ARK Innovation ETF, according to Morningstar.
- CBD Market
A look at Canadian cannabis exports
The CCSI was assessed at C$5.58 per gram this week, down 0.8% from last week’s C$5.63 per gram.
- CBD Market
Cannabis Investor Series from the Canadian Securities Exchange
During the month of May 2021, the Canadian Securities Exchange hosted a Cannabis Investor Series.
- Cultivation
Narc, narc: Who’s there? Complaints to Health Canada
Formal complaints to Health Canada about rival cannabis companies nearly doubled in 2020 compared to the previous year, according to a report from Marijuana Business Daily.
- Adult-Use
Why this cannabis pharmacy is taking aim at the OCS
As Canada’s first compounding pharmacy specializing in cannabis, Ottawa’s Hybrid Pharm has a unique position in the industry.












